AbCellera Biologics Inc. Common Shares (ABCL) Ownership & Trading Activity

Institutional holders, insider transactions, and congressional trades for ABCL. 13F holdings as of 2026-09-30.

In 13F filings for the quarter ended September 30, 2026, 115 institutions reported holding ABCL, with 56.1 million shares worth $808.2 million in aggregate.

Top Institutional Holders

InstitutionSharesValueChange
Capital Group13,579,116$198MDECREASED
TD Waterhouse Canada9,222,005$128MDECREASED
Marshall Wace8,958,273$131MINCREASED
BlackRock5,660,637$83MINCREASED
Arrowstreet Capital, Limited Partnership2,013,668$29MINCREASED

Recent Insider Trades

InsiderTypeSharesValueDate
Andrew Booth (Chief Financial Officer)BUY8,600$97K2026-11-13
Thermopylae Holdings Ltd. (10% Owner)GIFT125,0002026-11-13
Andrew Booth (Chief Financial Officer)EXERCISE50,000$16K2026-11-13
Andrew Booth (Chief Financial Officer)GIFT50,0002026-11-13
Andrew Booth (Chief Financial Officer)EXERCISE50,000$16K2026-11-13

Full institutional holdings, insider history, and congressional trades for AbCellera Biologics Inc. Common Shares on SentiSense.